Calcium is a vital mineral that plays a pivotal role in various physiological processes, including bone metabolism. Understanding this role is crucial for healthcare professionals, as it can aid in the prevention, diagnosis, and management of numerous bone-related disorders.
Calcium is the primary mineral found in bones and teeth, accounting for about 99% of the body's total calcium content. It is essential for maintaining bone strength and density. In addition to its structural role, calcium is involved in intracellular signaling, nerve transmission, muscle contraction, and blood clotting.
Calcium homeostasis is tightly regulated by the interplay of three hormones: parathyroid hormone (PTH), vitamin D, and calcitonin. PTH and vitamin D increase blood calcium levels by promoting bone resorption, the process by which osteoclasts break down bone and release the minerals, resulting in the transfer of calcium from bone fluid to the blood. Calcitonin, on the other hand, reduces blood calcium levels by inhibiting osteoclast activity and promoting bone formation by osteoblasts.
Disruptions in calcium homeostasis can result in bone diseases such as osteoporosis and rickets. Therefore, ensuring adequate calcium intake and maintaining calcium homeostasis are critical for bone health. Healthcare professionals should educate patients about the importance of dietary calcium and vitamin D, monitor blood and urine calcium levels, and consider bone density testing for at-risk patients.
In conclusion, calcium plays a crucial role in bone metabolism and overall bone health. As healthcare professionals, understanding this role and the mechanisms of calcium homeostasis can greatly enhance the prevention, diagnosis, and treatment of bone-related disorders.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation